MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation
- PMID: 15454082
- DOI: 10.1016/j.cell.2004.09.014
MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation
Abstract
The transcriptional repressor BCL-6 regulates B lymphocyte cell fate during the germinal center reaction by preventing terminal differentiation of B lymphocytes into plasma cells until appropriate signals are received. Here, we report a cofactor, MTA3, a cell type-specific subunit of the corepressor complex Mi-2/NuRD, for BCL-6-dependent cell fate determination. MTA3 is expressed in the same pattern in germinal centers as BCL-6. BCL-6 physically interacts with Mi-2/NuRD and this interaction is sensitive to BCL-6 acetylation status. Depletion of MTA3 by RNAi impairs BCL-6-dependent repression and alters the cell-specific transcriptional pattern characteristic of the B lymphocyte. Remarkably, exogenous expression of BCL-6 in a plasma cell line leads, in an MTA3-dependent manner, to repression of plasma cell-specific transcripts, reactivation of the B cell transcriptional program, expression of B lymphocyte cell surface markers, and reprogramming of cell fate.
Similar articles
-
Acetylation inactivates the transcriptional repressor BCL6.Nat Genet. 2002 Dec;32(4):606-13. doi: 10.1038/ng1018. Epub 2002 Oct 28. Nat Genet. 2002. PMID: 12402037
-
The human Mi-2/NuRD complex and gene regulation.Oncogene. 2007 Aug 13;26(37):5433-8. doi: 10.1038/sj.onc.1210611. Oncogene. 2007. PMID: 17694084 Review.
-
The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.J Pathol. 2007 Sep;213(1):106-15. doi: 10.1002/path.2199. J Pathol. 2007. PMID: 17573669
-
Mi-2/NuRD: multiple complexes for many purposes.Biochim Biophys Acta. 2004 Mar 15;1677(1-3):52-7. doi: 10.1016/j.bbaexp.2003.10.010. Biochim Biophys Acta. 2004. PMID: 15020045 Review.
-
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.Nature. 2004 Dec 2;432(7017):635-9. doi: 10.1038/nature03147. Nature. 2004. PMID: 15577913
Cited by
-
Discovery of Jaspamycin from marine-derived natural product based on MTA3 to inhibit hepatocellular carcinoma progression.Sci Rep. 2024 Oct 25;14(1):25294. doi: 10.1038/s41598-024-75205-7. Sci Rep. 2024. PMID: 39455636 Free PMC article.
-
Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictions.Clin Cancer Res. 2012 Sep 1;18(17):4538-48. doi: 10.1158/1078-0432.CCR-12-0217. Epub 2012 Jun 27. Clin Cancer Res. 2012. PMID: 22745106 Free PMC article. Review.
-
Epigenetic Control of B Cell Development and B-Cell-Related Immune Disorders.Clin Rev Allergy Immunol. 2016 Jun;50(3):301-11. doi: 10.1007/s12016-015-8494-7. Clin Rev Allergy Immunol. 2016. PMID: 26066671 Review.
-
CHD4/Mi-2beta activity is required for the positioning of the mesoderm/neuroectoderm boundary in Xenopus.Genes Dev. 2007 Apr 15;21(8):973-83. doi: 10.1101/gad.409507. Genes Dev. 2007. PMID: 17438000 Free PMC article.
-
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11294-9. doi: 10.1073/pnas.0903854106. Epub 2009 Jun 23. Proc Natl Acad Sci U S A. 2009. PMID: 19549844 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases